ArticleOncotarget2014

MBL-II-141, a chromone derivative, enhances irinotecan (CPT-11) anticancer efficiency in ABCG2-positive xenografts.

Léa Payen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.